Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Business & Regulation

Business & Regulation Supply Chain

A Digital Transformation in Supply

| Maryam Mahdi

Maeve Magner explains how digital solutions can improve the supply chains of emerging economies.

Business & Regulation Trends & Forecasts

Redefining Pharma

| James Strachan

Should pharma companies transition from developing, manufacturing and pricing “drugs” to promoting “health”?

Business & Regulation Business Practice

GDUFA 2020

| Stephanie Sutton

GDUFA fees for 2020 have been decided – and include a significant drop in the fees for finished dosage facilities.

Business & Regulation Trends & Forecasts

Inside the World’s Most Expensive Pharmaceutical Market

| Maryam Mahdi

As US prices for Rx drugs continues to rise, patients are finding themselves priced out of access to much-needed medicines.

Business & Regulation Digital Technologies

How the Industrial Internet of Things is Transforming Bioprocessing

| Sponsored by GE Healthcare

Digitalization means a more productive and adaptive plant through the application of analytics to leverage connectivity and data.

Business & Regulation Drug Discovery

Full SPaeDD Ahead

| Andrew Parker

SPaeDD, a collaborative effort between industry, academia and contractors, is helping to accelerate pediatric drug development in the UK..

Business & Regulation Profession

The Interface Between Art and Science

| Maryam Mahdi

When art and science meet, true inspiration can be found and tapped into.

Business & Regulation Supply Chain

Judging the New Kid on the Block

| Pasi Kemppainen

Is blockchain truly the solution the industry's been looking for?

Business & Regulation Trends & Forecasts

We Must Focus on Science, Not Geography

| Steve Arlington

In times of political and social upheaval, maintaining our links across borders and working closely together is more important than ever.

Business & Regulation Business Practice

Perpetual Preparedness

| James Strachan

With a no-deal Brexit still a real possibility, Merck continues to prepare for the worst case scenario.

Newsletter

Send me the latest from The Medicine Maker.

Sign up now

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register